Partial heart transplantation: Current applications and management

doi:10.5528/wjtm.124968

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Reference Citation Analysis (0)

(1)

(0)

(18)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Translational Medicine

ISSN

2220-6132

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Transl Med. Nov 28, 2026; 12(4): 124968
Published online Nov 28, 2026. doi: 10.5528/wjtm.124968

Table 2 Immunosuppression for partial heart transplantation[14]

	Aortic position	Pulmonary position
Intraoperative immunosuppression	Yes	Yes
Postoperative steroids	Yes	No
Mycophenolate	1 year	4-8 weeks
Tacrolimus	Indefinitely	Indefinitely

Institutional immunosuppression protocol reported by Overbey et al[14] for immunosuppression divided by implanted valve position.

Full Size Table

Citation: Sisson TM, Hill KD, Wolf SE, Turek JW, Overbey DM, Shea EV. Partial heart transplantation: Current applications and management. World J Transl Med 2026; 12(4): 124968
URL: https://www.wjgnet.com/2220-6132/full/v12/i4/124968.htm
DOI: https://dx.doi.org/10.5528/wjtm.124968

Sisson TM, Hill KD, Wolf SE, Turek JW, Overbey DM, Shea EV. Partial heart transplantation: Current applications and management. World J Transl Med 2026; 12(4): 124968 [DOI: 10.5528/wjtm.124968]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.